This study is testing the medication trontinemab to see if it helps people with early signs of Alzheimer's disease (AD), which is a brain disorder causing memory and thinking issues. People with mild cognitive impairment (MCI) or mild dementia due to AD can participate, meaning they show early signs but can still do daily activities.
You'll need to complete some tests like MRI (a type of brain scan) and PET (another scan) to check for signs of AD. A test called CSF can also be used if certain scans aren't available. You need to have good vision and hearing, even if it means using glasses or hearing aids.
- Length: The study duration is not mentioned, but you must be able to complete all parts.
- Visits: You will need to attend various tests and assessments.
- Risks: You shouldn't have other conditions affecting brain function or MRI restrictions.
How understandable was the trial content above?
Hard to understand
Easy to understand